Glenmark Pharmaceuticals (Not Rated)

CMP: Rs.2,203 Market Cap: Rs.622 bn

Investor day meet KTA’s

Summary
India business continues to be the largest and fastest growing segment for the company. It will continue to focus on cardiology and anti-diabetes therapies in this market. Current revenue mix is – India 34%, Emerging market 2…[Read more]

TechM 1QFY26 earnings call KTAs

•The demand environment remains uncertain due to tariff and policy risks. Discretionary spending remains cautious.
•Telecom vertical has stabilized and is showing signs of growth; Manufacturing (especially auto) and Hi-tech remain weak due to tariff uncertainty and client-specific cutbacks.
•BFSI remains resil…[Read more]

Listing Update – July 17, 2025

SMARTWORKS LIMITED
IPO Price: ₹407
Listing Price: ₹435
Listing Gain: ₹28 (+6.88%)
Lot Sizes:
• Retail: 36 shares
• HNI: 504 shares
Estimated Gains:
• Retail: ₹1,008
• HNI: ₹14,112

IPO Pipeline Update

SME IPO

Monarch Surveyors
Date : 22-24 July 2025
Price : 237-250
Size : 93.75 Cr
Lot : 600
LM : Beeline Ca…[Read more]

FII Radar: Top 31 Mid & Small Caps Gaining Strong Foreign Investor Interest

Tracking the latest FII holdings (%) and quarterly change reveals a sharp uptrend in strategic sectors like renewables, defence, chemicals, realty, and finance.

Top FII Additions (% Holding | Change)

Renewable Energy & Power
• Waaree Energies – 2.68% (+1…[Read more]

SEBI, RBI, and global regulatory actions from major economies as of July 17, 2025:

SEBI – India
• Jane Street ban & freeze order: SEBI barred Jane Street from Indian markets, impounded approximately US $567 million, and froze its accounts over allegations of manipulating Bank Nifty index on options expiry days

• Bond Central launch: SEBI introd…[Read more]

Nifty P/E ratio trend prior to Q1 earnings over the last 10 years, including current positioning:

Nifty P/E Ratio Before Q1 Results – Historical Trend

Year Nifty P/E (Pre-Q1 Earnings)

2024 23.22x
2023 23.35x
2022 20.73x
2021…[Read more]

Listing Update-July 16, 2025

CFF (FPO) – Mainboard
• IPO Price: ₹585
• Retail Lot Size: 400 shares
• HNI Lot Size: 600 shares
• Listing Price: ₹621
• Listing Gain:
o Retail: ₹14,400
o HNI: ₹21,600
• Listing Day Gain: +₹36 (+6.15%)

Asston Pharma – SME
• IPO Price: ₹123
• Retail Lot Size: 2,000 shares
• HNI Lot Size: 3,000 shares
• Listing Pric…[Read more]

Stocks recommendations -July 16, 2025

Retail & Lifestyle

Vishal Mega Mart (MOSL – Buy, TP ₹165)
• A unique retail play on Tier 2+ India’s rising aspirations.
• Operates in a ₹70T+ opportunity with 73% revenues from private labels.
• Focused on value retail across apparel (44%), GM (28%), and FMCG (28%).
• Double-digit growth across revenue/…[Read more]